Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Panjali Z et al. | 2022 | intact cell/cell culture, A549 (human lung cancer cell line) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Simko M et al. | 1998 | intact cell/cell culture, AFC cells (human amniotic fluid cell line) and SCL II cells (human squamous cell carcinoma cell line) | magnetic field, 50/60 Hz | 1 mT |
Simko M et al. | 1998 | intact cell/cell culture, AFC cells (human amniotic fluid cells) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Del Re B et al. | 2012 | intact cell/cell culture, BE(2)C cells (human neuroblastoma cells) transfected with plasmids for retro-transposition | magnetic field, signals/pulses, 50/60 Hz | 1 mT |
Maes A et al. | 2015 | intact cell/cell culture, C3A cells (clonal derivative of Hep G2, a human liver carcinoma cell line) | magnetic field, 50/60 Hz | 5–500 µT |
Cho YH et al. | 2007 | intact cell/cell culture, CCD-986sk (human fibroblasts) | magnetic field, low frequency, 50/60 Hz, co-exposure | 0.8 mT |
Shen Y et al. | 2016 | intact cell/cell culture, CHL (Chinese hamster lung) cells | magnetic field, 50/60 Hz | - |
Reese JA et al. | 1988 | intact cell/cell culture, CHO (Chinese hamster ovary) cells | electric field, magnetic field, 50/60 Hz | 100 µT–2 mT |
Walleczek J et al. | 1999 | intact cell/cell culture, CHO (Chinese hamster ovary) cells | magnetic field, 50/60 Hz, co-exposure | 0.23–0.7 mT |
Cantoni O et al. | 1996 | intact cell/cell culture, CHO (Chinese hamster ovary) cells, CCRF-CEM cells (human acute T-lymphoblastoid leukemia) and Mc Coy cells (mouse fibroblast cell line) | electric field, magnetic field, 50/60 Hz, co-exposure | 0.2 µT–0.2 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.